Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0136 USD | -14.47% | +13.33% | -78.75% |
Financials (USD)
Sales 2022 | 16.84 | Sales 2023 | 18.22 | Capitalization | 1.28M |
---|---|---|---|---|---|
Net income 2022 | -76M | Net income 2023 | 53M | EV / Sales 2022 | 4,528,434 x |
Net Debt 2022 | 68.36M | Net Debt 2023 | 43.37M | EV / Sales 2023 | 2,451,077 x |
P/E ratio 2022 |
-0.05
x | P/E ratio 2023 |
1.2
x | Employees | 38 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Latest transcript on Evofem Biosciences, Inc.
1 day | -14.47% | ||
1 week | +13.33% | ||
Current month | -2.86% | ||
1 month | -14.47% | ||
3 months | -55.26% | ||
6 months | -79.08% | ||
Current year | -78.75% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 12-12-31 | |
Ivy Zhang
DFI | Director of Finance/CFO | 46 | 18-02-28 |
Amy Raskopf
IRC | Investor Relations Contact | - | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 12-12-31 | |
Kim Kamdar
BRD | Director/Board Member | 56 | 17-12-31 |
Colin Rutherford
BRD | Director/Board Member | 65 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.0136 | -14.47% | 245,058 |
24-05-09 | 0.0159 | +3.92% | 612,039 |
24-05-08 | 0.0153 | +12.92% | 420,915 |
24-05-07 | 0.0136 | -2.52% | 568,467 |
24-05-06 | 0.0139 | +15.83% | 1,324,803 |
Delayed Quote OTC Markets, May 10, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-78.75% | 830K | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- EVFM Stock